BRPI0511125A - usos de ácido 5,6,7-triidroxieptanóico seus e análogos - Google Patents

usos de ácido 5,6,7-triidroxieptanóico seus e análogos

Info

Publication number
BRPI0511125A
BRPI0511125A BRPI0511125-0A BRPI0511125A BRPI0511125A BR PI0511125 A BRPI0511125 A BR PI0511125A BR PI0511125 A BRPI0511125 A BR PI0511125A BR PI0511125 A BRPI0511125 A BR PI0511125A
Authority
BR
Brazil
Prior art keywords
analogues
trihydroxyheptanoic acid
trihydroxyheptanoic
acid
uveitis
Prior art date
Application number
BRPI0511125-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Peter G Klimko
Mark R Hellberg
Daniel A Gamache
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of BRPI0511125A publication Critical patent/BRPI0511125A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
BRPI0511125-0A 2004-05-14 2005-05-12 usos de ácido 5,6,7-triidroxieptanóico seus e análogos BRPI0511125A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57116204P 2004-05-14 2004-05-14
PCT/US2005/016646 WO2005112905A1 (en) 2004-05-14 2005-05-12 Method of treating dry eye disorders and uveitis

Publications (1)

Publication Number Publication Date
BRPI0511125A true BRPI0511125A (pt) 2007-11-27

Family

ID=34968761

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0511125-0A BRPI0511125A (pt) 2004-05-14 2005-05-12 usos de ácido 5,6,7-triidroxieptanóico seus e análogos

Country Status (19)

Country Link
US (1) US20050256189A1 (enExample)
EP (1) EP1744736B1 (enExample)
JP (2) JP4993299B2 (enExample)
KR (1) KR101170885B1 (enExample)
CN (1) CN100522147C (enExample)
AT (1) ATE448779T1 (enExample)
AU (1) AU2005244839B2 (enExample)
BR (1) BRPI0511125A (enExample)
CA (1) CA2563659C (enExample)
CY (1) CY1109666T1 (enExample)
DE (1) DE602005017762D1 (enExample)
DK (1) DK1744736T3 (enExample)
ES (1) ES2334368T3 (enExample)
MX (1) MXPA06013170A (enExample)
PL (1) PL1744736T3 (enExample)
PT (1) PT1744736E (enExample)
SI (1) SI1744736T1 (enExample)
WO (1) WO2005112905A1 (enExample)
ZA (1) ZA200609220B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005304733B2 (en) 2004-11-09 2011-04-07 Alcon, Inc. 5,6,7-trihydroxyheptanoic acid and analogs for the treatment of ocular diseases and diseases associated with hyperproliferative and angiogenic responses
US7687539B1 (en) 2005-11-07 2010-03-30 Alcon Research, Ltd. Method of treating ocular allergy
TW201010727A (en) * 2008-09-03 2010-03-16 Alcon Res Ltd Pharmaceutical composition having relatively low ionic strength
WO2011096941A1 (en) * 2010-02-08 2011-08-11 Alcon Research, Ltd. Method of treating ocular allergy
JP2013521230A (ja) * 2010-02-25 2013-06-10 アルコン リサーチ， リミテッド 角膜創傷治癒を促進する方法
WO2012112873A2 (en) 2011-02-18 2012-08-23 3M Innovative Properties Company Flexible light emitting semiconductor device
KR102593305B1 (ko) * 2020-11-25 2023-10-25 서울대학교 산학협력단 인공지능 기반 의류 사이즈 추천 방법 및 시스템

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4131651A (en) * 1977-10-25 1978-12-26 Barnes-Hind Pharmaceuticals, Inc. Treatment of dry eye
US4409205A (en) * 1979-03-05 1983-10-11 Cooper Laboratories, Inc. Ophthalmic solution
US4370325A (en) * 1979-03-30 1983-01-25 Dermik Laboratories Pharmaceutical compositions and method of treatment
US4883658A (en) * 1986-04-28 1989-11-28 Holly Frank J Ophthalmic solution for treatment of dry-eye syndrome
US4744980A (en) * 1986-04-28 1988-05-17 Holly Frank J Ophthalmic solution for treatment of dry eye syndrome
US4818537A (en) * 1986-10-21 1989-04-04 Liposome Technology, Inc. Liposome composition for treating dry eye
US4966773A (en) * 1986-11-25 1990-10-30 Alcon Laboratories, Inc. Topical ophthalmic compositions containing microfine retinoid particles
US4914088A (en) * 1987-04-02 1990-04-03 Thomas Glonek Dry eye treatment solution and method
US5278151A (en) * 1987-04-02 1994-01-11 Ocular Research Of Boston, Inc. Dry eye treatment solution
US5075104A (en) * 1989-03-31 1991-12-24 Alcon Laboratories, Inc. Ophthalmic carboxy vinyl polymer gel for dry eye syndrome
US5174988A (en) * 1989-07-27 1992-12-29 Scientific Development & Research, Inc. Phospholipid delivery system
US5041434A (en) * 1991-08-17 1991-08-20 Virginia Lubkin Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
ZA912797B (en) * 1990-05-29 1992-12-30 Boston Ocular Res Dry eye treatment process and solution
EP0459148B1 (en) * 1990-05-29 1996-01-03 Ocular Research Of Boston Inc. Dry eye treatment composition
ZA927277B (en) * 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
US5958912A (en) * 1992-04-21 1999-09-28 The Schepens Eye Research Institute, Inc. Ocular therapy in keratoconjunctivitis sicca using topically applied androgens of TGF-β
US5290572A (en) * 1992-08-06 1994-03-01 Deo Corporation Opthalmic composition for treating dry eye
US5441951A (en) * 1994-06-15 1995-08-15 Brigham & Women's Hospital Lipoxin compounds
US5696166A (en) * 1995-10-31 1997-12-09 Yanni; John M. Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
WO1997020578A1 (en) * 1995-12-04 1997-06-12 University Of Miami Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance
US5800807A (en) * 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol
EP1237549B1 (en) * 1999-11-09 2004-02-04 Alcon, Inc Lipoxin a4 and analogues for the treatment of dry eye

Also Published As

Publication number Publication date
KR101170885B1 (ko) 2012-08-07
WO2005112905A1 (en) 2005-12-01
ES2334368T3 (es) 2010-03-09
JP4993299B2 (ja) 2012-08-08
CY1109666T1 (el) 2014-08-13
AU2005244839A2 (en) 2005-12-01
EP1744736B1 (en) 2009-11-18
CA2563659A1 (en) 2005-12-01
PL1744736T3 (pl) 2010-03-31
EP1744736A1 (en) 2007-01-24
JP2012107053A (ja) 2012-06-07
CN1953740A (zh) 2007-04-25
AU2005244839B2 (en) 2009-12-24
DK1744736T3 (da) 2010-02-15
MXPA06013170A (es) 2007-02-13
US20050256189A1 (en) 2005-11-17
DE602005017762D1 (de) 2009-12-31
ATE448779T1 (de) 2009-12-15
KR20070011582A (ko) 2007-01-24
CN100522147C (zh) 2009-08-05
JP2007537282A (ja) 2007-12-20
PT1744736E (pt) 2010-01-05
ZA200609220B (en) 2009-02-25
SI1744736T1 (sl) 2010-01-29
AU2005244839A1 (en) 2005-12-01
CA2563659C (en) 2012-03-20

Similar Documents

Publication Publication Date Title
NO20071095L (no) Hittil ukjente tiofenderivater
BRPI0418251A (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos para o tratamento de doenças virais
BR0314603A (pt) Uso de inibidores da sìntese de citoquina para o tratamento de distúrbios de olhos secos
BRPI0509369A (pt) azaindóis úteis como inibidores de jak e outras proteìna cinases
UY27872A1 (es) Inhibidores de caspasa y usos de los mismos.
SE0301653D0 (sv) Novel compounds
EA201170703A1 (ru) Производные адамантилбензамида
TW200612905A (en) Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
TW200611702A (en) Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
DK1620113T3 (da) Topisk formulering af ivermectin til behandling af dermatologiske lidelser
DK1263504T3 (da) Anvendelse af forbindelser med 5-HT1A aktivitet, som er anvendelige til behandling af lidelser i den ydre retina
EA200701845A1 (ru) Рофлумиласт для лечения сахарного диабета
TR200400526T4 (tr) Göz kurumasının tedavisi için lipoksin A4 ve analogları
ATE534652T1 (de) Phosphono-pent-2-en-1-yl-nukleoside und analoga
CY1109666T1 (el) Μεθοδος θεραπειας διαταραχων ξηροφθαλμιας και ραγοειδιτιδας
EE05357B1 (et) Tablett, mis sisaldab v„hemalt kahte eristatavat segmenti, ning selle kasutamine
DK1463735T3 (da) Imidazo-2,1-B -1,3,4-thiadiazol-sulfonamider
NO20014241D0 (no) C16-umettede FP-selektive prostaglandinanaloger
TW200744567A (en) Phenylethylamine analogs and their use for treating glaucoma
CY1107562T1 (el) Χρηση των ν-(2-αρυλ-προπιονυλ)-σουκλφοναμιδιων για τη θepαπεια του τραυματος του νωτιαιου μυελου
GB0326633D0 (en) Therapeutic agents
DK1853232T3 (da) Stabil krystallin form af bifeprunox mesylat, doseringsformer deraf og fremgangsmåder for deres anvendelse
HRP20090513T1 (hr) S-mirtazapin, namijenjen liječenju napadaja vrućine
ATE548043T1 (de) Polymorphe von 3-o-(3',3'- dimethylsuccinyl)betulinsäure-di-n-methyl-d- glucamin
DE602004009166D1 (de) Neue Analoga von Nitrobenzylthioinosin

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2257 DE 08/04/2014.